Additional file 6: Table S6: Cluster analysis of proteins modulated in the plasma of COVID-19 patients
Table S3. Peptidomics data on human proteome as produced using PEAKS software. (XLSX 87 kb
Additional file 1. Fig. S1: Distribution and quality control of the total proteins detected
Provided here are the supplementary information for the below manuscript published in Immunity entit...
Additional file 5: Table S5: Analysis of biological processes associated to the proteins altered in ...
Additional file 4: Table S4: Proteins with statistically different levels in COVID-19 patients
Additional file 1: Tables S1: Demographics, clinical baseline characteristics, therapy and cause of ...
Additional file 3: Table S3: MaxQuant software identification of proteins from plasma of COVID-19 pa...
Additional file 2: Tables S2: MaxQuant software analysis of peptides detected by mass spectrometry f...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
This dataset comprises of supplementary files for the comprehensive proteomics-based investigation o...
Table S3. Peptidomics data on human proteome as produced using PEAKS software. (XLSX 87 kb
Additional file 1. Fig. S1: Distribution and quality control of the total proteins detected
Provided here are the supplementary information for the below manuscript published in Immunity entit...
Additional file 5: Table S5: Analysis of biological processes associated to the proteins altered in ...
Additional file 4: Table S4: Proteins with statistically different levels in COVID-19 patients
Additional file 1: Tables S1: Demographics, clinical baseline characteristics, therapy and cause of ...
Additional file 3: Table S3: MaxQuant software identification of proteins from plasma of COVID-19 pa...
Additional file 2: Tables S2: MaxQuant software analysis of peptides detected by mass spectrometry f...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while 20% of patie...
This dataset comprises of supplementary files for the comprehensive proteomics-based investigation o...
Table S3. Peptidomics data on human proteome as produced using PEAKS software. (XLSX 87 kb
Additional file 1. Fig. S1: Distribution and quality control of the total proteins detected
Provided here are the supplementary information for the below manuscript published in Immunity entit...